Multiple generic drug manufacturers drive prices down through competition. When more companies make the same drug, prices fall sharply-often by over 70%. This system saves billions annually but is at risk from market consolidation.
Brand companies launch authorized generics not to lose money, but to keep it. By selling their own exact drug at generic prices, they prevent total revenue collapse when patents expire - and keep patients on trusted medications.